Berger Montague PC Investigating Potential Claims on Behalf...
featured news
September 16, 2015
General
Walter Investment Management Corporation Settles Mortgage Fraud Case for $29 Million
In yet another mortgage fraud case, Walter Investment Management Corporation (Walter Investment) has agreed to pay over $29 million to resolve allegations it falsely certified residential home mortgages under the Department of Housing and Urban Development’s (HUD) Home Equity Conversion Mortgage (HECM)[1] program. The alleged scheme was uncovered following a […]
September 15, 2015
General
Parsons Infrastructure & Technology Group Settles Allegations of Contractor Fraud for $3.8 Million
The Savannah River Site is a nuclear facility built in the 1950s and maintained by the federal government via several contracts with engineering and environmental firms. According to its mission statement, the site is “a key Department of Energy (DOE) industrial complex responsible for environmental stewardship, environmental cleanup, waste management […]
September 14, 2015
General
K-Mart Pharmacy Accused of Defrauding Medicare; Settles for $1.4 Million
Much like healthcare providers are prohibited from providing kickbacks to doctors and patients, pharmacies are likewise prohibited from inducing potential customers by offering financial incentives to choose one dispensary over another. In essence, the government seeks to ensure Medicare enrollees are free to choose the pharmacy of their liking without […]
September 9, 2015
General
The Growing Problem of Data Falsification by Overseas Drug Manufacturers
In yesterday’s post, we reviewed a controversial phenomenon plaguing the international drug market involving the production of substandard generic medications in India. More specifically, we looked at how patients in America and worldwide could face harm by taking drugs manufactured by companies like Ranbaxy, as studies have revealed that key […]
September 8, 2015
General
Potential Dangers Lurking in Generic Drugs Manufactured in India
Over the next two posts, we’ll explore a growing international problem involving the safety of generic drugs produced overseas. Namely, generic medications produced in India – including those manufactured by False Claims Act offender Ranbaxy – are becoming more and more problematic, due in part to the alleged falsification of […]featured investigations
$2.4B+
in 2025 post-trial judgments
$55B+
in Settlements & Verdicts
55+
Years of Experience With High-Profile Cases
100+
Attorneys Protecting Your Rights
20+
Years Ranked as Top Law Firm by Chambers USA
50
States in Which The Firm Has Successfully Litigated
